0001578563-19-000025.txt : 20190829
0001578563-19-000025.hdr.sgml : 20190829
20190829170353
ACCESSION NUMBER: 0001578563-19-000025
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190827
FILED AS OF DATE: 20190829
DATE AS OF CHANGE: 20190829
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Pedder Simon
CENTRAL INDEX KEY: 0001316736
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37590
FILM NUMBER: 191067097
MAIL ADDRESS:
STREET 1: 1001 MAIN STREET
STREET 2: SUITE 600
CITY: BUFFALO
STATE: NY
ZIP: 14203
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Cerecor Inc.
CENTRAL INDEX KEY: 0001534120
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 450705648
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 540 GAITHER ROAD
STREET 2: SUITE 400
CITY: ROCKVILLE
STATE: MD
ZIP: 20850
BUSINESS PHONE: 410-522-8707
MAIL ADDRESS:
STREET 1: 540 GAITHER ROAD
STREET 2: SUITE 400
CITY: ROCKVILLE
STATE: MD
ZIP: 20850
4
1
primary_doc.xml
PRIMARY DOCUMENT
X0306
4
2019-08-27
0
0001534120
Cerecor Inc.
CERC
0001316736
Pedder Simon
C/O CERECOR INC.
540 GAITHER ROAD, SUITE 400
ROCKVILLE
MD
20850
1
1
0
0
Executive Chairman of the Bd
Common Stock
2019-08-27
4
P
0
6734
2.9849
A
262734
D
Stock Option (Right to Buy)
5.44
2019-06-28
2029-06-28
Common Stock
117
117
D
Stock Option (Right to Buy)
4.98
2029-05-24
Common Stock
300000
300000
D
Stock Option (Right to Buy)
5.17
2029-04-15
Common Stock
300000
300000
D
Stock Option (Right to Buy)
5.84
2029-03-29
Common Stock
882
882
D
Stock Option (Right to Buy)
3.23
2028-12-31
Common Stock
1504
1504
D
Stock Option (Right to Buy)
4.67
2028-09-28
Common Stock
990
990
D
Stock Option (Right to Buy)
4.34
2028-06-29
Common Stock
1012
1012
D
Stock Option (Right to Buy)
3.71
2028-05-14
Common Stock
8357
8357
D
Stock Option (Right to Buy)
4.14
2028-04-06
Common Stock
16714
16714
D
This transaction was executed in multiple trades ranging from $2.97 to $2.9941. The price reported in Column 4 is a weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder full information regarding the number of shares and prices at which the transactions were effected.
Granted for service on the Board of Directors as a non-employee Board member prior to appointment to Executive Chairman of the Board.
The stock option was granted on May 24, 2019. One-third of the shares subject to the option will vest upon the Issuer's common stock closing at or above $8.00 per share for three consecutive trading days. The next one-third of the shares subject to the option will vest upon the Issuer's common stock closing at or above $10.50 per share for three consecutive trading days. The final one-third of the shares subject to the option will vest upon the Issuer's common stock closing at or above $13.00 per share for three consecutive trading days.
The stock option was granted on April 15, 2019. One-third of the shares subject to the stock option will vest on the first anniversary of the date of grant, and the remaining two-thirds of the shares subject to the stock option will vest in equal monthly installments over the following 24 months, provided the Reporting Person is then still providing continuous service as an employee, director or consultant.
The stock option is fully vested.
The stock option will vest in three substantially equal installments on April 6, 2019, 2020 and 2021, provided the Reporting Person is then still providing continuous service as an employee, director or consultant.
/s/ Donald R. Reynolds, by Power of Attorney
2019-08-29